Latest filing published 23 Apr 2026 for Day One Biopharmaceuticals, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Lauren Merendino span 2 companies, the busiest being Myovant Sciences Ltd. and Day One Biopharmaceuticals, Inc. We count 11 filings; the first trade dates from 15 April 2022 and the latest from 23 April 2026.
On the market, this insider has only sold: 4 sales, €183k in total. Outside the open market, there are 1 share grant and 4 option exercises.
The latest filing, published on 23 April 2026, reports a transaction in Day One Biopharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations